Angiotech Pharmaceuticals Completes Acquisition of Quill Medical, Inc. June 28, 2006 AnorMED provides outlook for fiscal 2007 June 13, 2006 AnorMed to present at the fifth annual Needham Biotechnology Conference June 9, 2006    AnorMED to present at the Pacific Growth Equities Life Sciences Conference June 8, 2006 Aspreva Pharmaceuticals appoints William L. Hunter, CEO of Angiotech Pharmaceuticals, to its Board of Directors June 13, 2006 Aspreva and Roche Receive Orphan Drug Designation from FDA for Evaluation of CellCept in Rare Autoimmune Disease Pemphigus Vulgaris June 6, 2006  biolytical Laboratories: INSTI(TM) a 60 second HIV testing kit is now available to the European Community June 27, 2006 CANTEST plans $9.5 million expansion of Burnaby facilities June 21, 2006  Cardiome Appoints Sikorsky as Chief Financial Officer June 13, 2006 Celator Pharmacueticals Appoints Industry Veteran Felix Botelho as Head of Commercial Development June 26, 2006  Chemokine Therapeutics names Guy Ely, MD as Chief Medical Officer June 28, 2006  Chromos appoints new Vice President, Finance and Chief Financial Officer June 14, 2006  CIHR/MSFHR Bioinformatics Industrial Research Rotation Program: Call for Company Participants June 30, 2006 Dorsey & Whitney Educate Members on US Patent Changes June 27, 2006 Forbes Medi-Tech to Showcase Reducol™-Based Products at the Institute of Food Technologists Annual Meeting and Food Expo in Orlando, Florida June 22, 2006  Forbes Strengthens Presence in Europe with Fayrefield Foods Venture New Venture To Expand Distribution of Reducol™based Products in Continental Europe June 20, 2006  Forbes Medi-Tech Announces Launch of Reducol™-Based Products at Albert Heijn June 15, 200 Forbes Announces Completion of Enrollment for FM-VP4 US Phase II Trial June 13, 2006 Leading Proteomics Company Genologics Life Sciences Software Inc. Breaks into Genomics Market With Solution for Cross-Science Systems Biology Research June 26, 2006  iCo Therapeutics Welcomes Dr. Jason Slakter to Strategic Advisory Board June 28, 2006 iCo Therapeutics Recruits Leading Ophthalmologist to Strategic Advisory Board June 14, 2006 Inex Announces Settlement of Convertible Debt and Provides Corporate Update June 20, 2006 Inflazyme Pharmaceuticals and BioSeek Sign Research Collaboration Agreement on LSAIDs June 26, 2006  Med BioGene Inc. signs letter of intent with the Ontario Institute for Cancer Research June 23, 2006  MIGENIX Completes Enrollment of Celgosivir (MX-3253) Phase IIb HCV Combination Study June 15, 2006  Nventa strengthens patent portfolio with two new European Patents for HPV-related diseases June 20, 2006 Nventa announces positive HspE7 data from NCI-sponsored clinical trial in HIV-positive patients June 15, 2006   Nventa granted European patent covering heat shock protein fusion to treat influenza June 7, 2006 Dr. Ian J. Massey Joins QLT's Board of Directors June 13, 2006 QSV Biologics, Ltd., and Proteon Therapeutics, Inc., Enter into a Contract for Process Development and Manufacture of PRT-201 June 21, 2006  Perceptronix raises CDN$5.5M June 20, 2006 Protox Therapeutics Retains Leading Investor Relations Firm June 23, 2006 Protox Announces Changes to Board of Directors June 19, 2006 Protox Therapeutics to Present at London Biotech Investment Forum June 15, 2006 Protox Strengthens Intellectual Property Portfolio with New Patent Application June 14, 2006   Protox Therapeutics to Present at Technology and Life Sciences Forum June 9, 2006 UBC: Canada and California forge a strategic innovation partnership June 22, 2006  UBC Researchers Find Stroke Death Channel June 7, 2006 WEX Pharmaceuticals: FDA Approves Investigational New Drug Application June 12, 2006

send this to a friend unsubscrive © BC BIOTECH. All rights reserved.

Suite 900 - 1188 West Georgia St. Vancouver, BC V6E 4A2